Home Adcentrx Therapeutics' ADRX-0405 Receives IND Approval from NMPA for Advanced Solid Tumors

Adcentrx Therapeutics' ADRX-0405 Receives IND Approval from NMPA for Advanced Solid Tumors

Jun 09, 2026 16:20 CST Updated 17:17